Healthequity Tangible Asset Value Over Time

HQY
 Stock
  

USD 60.09  2.75  4.80%   

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check Healthequity Performance and Healthequity Correlation.
  
Average Assets is likely to rise to about 3.4 B in 2022, whereas Tangible Asset Value is likely to drop slightly above 418.3 M in 2022.

Healthequity Quarterly Tangible Asset Value

411.37 Million

Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Tangible Asset Value Analysis

Compare Healthequity and related stocks such as Starbucks Corp, JP Morgan Chase, Bank Of America, 3M Company, Johnson Johnson, Boeing Company, International Business, Alcoa Corp, and Coca-Cola Tangible Asset Value Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
SBUX4.2 B12.1 B12.1 B12.1 B12.1 B12.1 B7.7 B7.7 B7.7 B7.7 B7.7 B6.9 B6.2 B
JPM2214.4 B2214.4 B2308.7 B2366 B2523.4 B2303.4 B2436.7 B2479.2 B2568.2 B2634 B3331.3 B3686.9 B3459 B
BAC2043.5 B2043.5 B2127.5 B2021.8 B2026.6 B2070.8 B2119.1 B2212.3 B2285.6 B2365.1 B2750.7 B3100.5 B2954.1 B
MMM22.7 B22.7 B24.6 B24.5 B22.7 B21 B21.4 B24.5 B23.8 B24.8 B27.7 B28.3 B28.9 B
JNJ79.4 B79.4 B91.5 B91.5 B91.5 B91.5 B91.5 B72.2 B100.4 B100.4 B100.4 B100.4 B90.8 B
BA72 B72 B80.8 B84.6 B84.9 B86.6 B82.1 B104.2 B106.1 B122.2 B141.2 B127.9 B124.8 B
IBM86.8 B86.8 B86.2 B91.2 B83.6 B75 B76.6 B84.8 B84 B78.7 B88.5 B63.8 B68 B
AA18.5 B18.5 B18.5 B18.5 B18.5 B16.4 B16.7 B17.4 B16.1 B14.6 B14.9 B15 B14.7 B
KO52.3 B52.3 B58.8 B62.4 B65.7 B65.9 B66.1 B71.3 B61.6 B59.6 B58.7 B59.7 B67.3 B

Healthequity and related stocks such as Starbucks Corp, JP Morgan Chase, Bank Of America, 3M Company, Johnson Johnson, Boeing Company, International Business, Alcoa Corp, and Coca-Cola Tangible Asset Value description

The value of tangibles assets calculated as the difference between Total Assets and Goodwill and Intangible Assets.

My Equities

My Current Equities and Potential Positions

AMN - USA Stock
Amn Healthcare Services
AMN
Amn Healthcare Fama & French Business Services
Business Services
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
USD 117.83
Please check Healthequity Performance and Healthequity Correlation. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.